FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108545239> ?p ?o ?g. }

• W2108545239 abstract "Fluticasone furoate (FF) is a novel, once-daily inhaled corticosteroid (ICS) that has been shown to improve lung function vs. placebo in asthma patients. This study evaluated the efficacy and safety of FF 50 mcg compared with placebo in asthma patients uncontrolled by non-ICS therapy. This 12-week, multicentre, randomized, double-blind, placebo-controlled, parallel-group, phase III study randomized 248 patients (aged ≥12 years) to once-daily FF 50 mcg administered via the ELLIPTA™a dry powder inhaler or placebo. The primary endpoint was change from baseline in pre-dose evening trough forced expiratory volume in one second (FEV1). Secondary endpoints were change from baseline in percentage of rescue-free 24-h periods (powered), evening and morning peak expiratory flow, symptom-free 24-h periods and withdrawals due to lack of efficacy. Other endpoints included Asthma Control Test™, Asthma Quality of Life Questionnaire and ELLIPTA ease of use questions. Safety was assessed throughout the study. There was a significant difference in evening trough FEV1 between FF 50 mcg and placebo (treatment difference: 120 mL; p = 0.012). There was also a significant difference in rescue-free 24-h periods (11.6%; p = 0.004) vs. placebo. There were numerically greater improvements with FF vs. placebo for all remaining secondary endpoints. The incidence of adverse events was lower with FF (31%) than with placebo (38%); few were treatment-related (FF 50 mcg: n = 1, <1%; placebo: n = 4, 3%). FF 50 mcg once daily significantly improved FEV1 and percentage of rescue-free 24-h periods experienced over 12 weeks vs. placebo, and was well tolerated. www.clinicaltrials.gov , registration number: NCT01436071" @default.
• W2108545239 created "2016-06-24" @default.
• W2108545239 creator A5001571542 @default.
• W2108545239 creator A5026242254 @default.
• W2108545239 creator A5028344690 @default.
• W2108545239 creator A5036067413 @default.
• W2108545239 creator A5044980958 @default.
• W2108545239 creator A5045967209 @default.
• W2108545239 creator A5048656238 @default.
• W2108545239 creator A5064031726 @default.
• W2108545239 creator A5090062530 @default.
• W2108545239 date "2014-08-11" @default.
• W2108545239 modified "2023-09-22" @default.
• W2108545239 title "Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial" @default.
• W2108545239 cites W1988184947 @default.
• W2108545239 cites W2026180619 @default.
• W2108545239 cites W2026254946 @default.
• W2108545239 cites W2030556594 @default.
• W2108545239 cites W2062765710 @default.
• W2108545239 cites W2067282397 @default.
• W2108545239 cites W2068198910 @default.
• W2108545239 cites W2076199084 @default.
• W2108545239 cites W2083018626 @default.
• W2108545239 cites W2088340248 @default.
• W2108545239 cites W2091295600 @default.
• W2108545239 cites W2096767019 @default.
• W2108545239 cites W2116744855 @default.
• W2108545239 cites W2133743316 @default.
• W2108545239 cites W2171365228 @default.
• W2108545239 doi "https://doi.org/10.1186/s12931-014-0088-z" @default.
• W2108545239 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4256920" @default.
• W2108545239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25108545" @default.
• W2108545239 hasPublicationYear "2014" @default.
• W2108545239 type Work @default.
• W2108545239 sameAs 2108545239 @default.
• W2108545239 citedByCount "18" @default.
• W2108545239 countsByYear W21085452392015 @default.
• W2108545239 countsByYear W21085452392016 @default.
• W2108545239 countsByYear W21085452392018 @default.
• W2108545239 countsByYear W21085452392019 @default.
• W2108545239 countsByYear W21085452392020 @default.
• W2108545239 countsByYear W21085452392022 @default.
• W2108545239 countsByYear W21085452392023 @default.
• W2108545239 crossrefType "journal-article" @default.
• W2108545239 hasAuthorship W2108545239A5001571542 @default.
• W2108545239 hasAuthorship W2108545239A5026242254 @default.
• W2108545239 hasAuthorship W2108545239A5028344690 @default.
• W2108545239 hasAuthorship W2108545239A5036067413 @default.
• W2108545239 hasAuthorship W2108545239A5044980958 @default.
• W2108545239 hasAuthorship W2108545239A5045967209 @default.
• W2108545239 hasAuthorship W2108545239A5048656238 @default.
• W2108545239 hasAuthorship W2108545239A5064031726 @default.
• W2108545239 hasAuthorship W2108545239A5090062530 @default.
• W2108545239 hasBestOaLocation W21085452391 @default.
• W2108545239 hasConcept C121332964 @default.
• W2108545239 hasConcept C126322002 @default.
• W2108545239 hasConcept C1276947 @default.
• W2108545239 hasConcept C142724271 @default.
• W2108545239 hasConcept C168563851 @default.
• W2108545239 hasConcept C19720800 @default.
• W2108545239 hasConcept C197934379 @default.
• W2108545239 hasConcept C203092338 @default.
• W2108545239 hasConcept C204787440 @default.
• W2108545239 hasConcept C27081682 @default.
• W2108545239 hasConcept C2776042228 @default.
• W2108545239 hasConcept C2776476923 @default.
• W2108545239 hasConcept C2777419714 @default.
• W2108545239 hasConcept C2779028295 @default.
• W2108545239 hasConcept C2780261241 @default.
• W2108545239 hasConcept C42219234 @default.
• W2108545239 hasConcept C71924100 @default.
• W2108545239 hasConceptScore W2108545239C121332964 @default.
• W2108545239 hasConceptScore W2108545239C126322002 @default.
• W2108545239 hasConceptScore W2108545239C1276947 @default.
• W2108545239 hasConceptScore W2108545239C142724271 @default.
• W2108545239 hasConceptScore W2108545239C168563851 @default.
• W2108545239 hasConceptScore W2108545239C19720800 @default.
• W2108545239 hasConceptScore W2108545239C197934379 @default.
• W2108545239 hasConceptScore W2108545239C203092338 @default.
• W2108545239 hasConceptScore W2108545239C204787440 @default.
• W2108545239 hasConceptScore W2108545239C27081682 @default.
• W2108545239 hasConceptScore W2108545239C2776042228 @default.
• W2108545239 hasConceptScore W2108545239C2776476923 @default.
• W2108545239 hasConceptScore W2108545239C2777419714 @default.
• W2108545239 hasConceptScore W2108545239C2779028295 @default.
• W2108545239 hasConceptScore W2108545239C2780261241 @default.
• W2108545239 hasConceptScore W2108545239C42219234 @default.
• W2108545239 hasConceptScore W2108545239C71924100 @default.
• W2108545239 hasIssue "1" @default.
• W2108545239 hasLocation W21085452391 @default.
• W2108545239 hasLocation W21085452392 @default.
• W2108545239 hasLocation W21085452393 @default.
• W2108545239 hasLocation W21085452394 @default.
• W2108545239 hasLocation W21085452395 @default.
• W2108545239 hasOpenAccess W2108545239 @default.
• W2108545239 hasPrimaryLocation W21085452391 @default.
• W2108545239 hasRelatedWork W1673711990 @default.
• W2108545239 hasRelatedWork W1942079596 @default.
• W2108545239 hasRelatedWork W1991683671 @default.
• W2108545239 hasRelatedWork W2000737149 @default.

• next